Incontinentia pigmenti (IP) is an X-linked dominant disorder that is seen in females. Although the medical literature has focused strongly on the skin manifestations of IP, there is lack of comprehensive reviews focused on delayed nail lesions of IP. The authors thus tabulated reported nail changes in IP with a focus on diagnosis and management of this delayed nail presentations. This review emphasizes several observations with strong clinical relevance to management of IP. In particular, nail lesions may be additional clue to vague or late-presenting cases of IP. Nail lesions are most common on the first three digits of the hands, can affect multiple digits on multiple limbs, present from three to 45 years of age, and present on average over 20 years after skin lesions present. Clinically, nail lesions can be subtle and often are indicators of underlying tumor. Finally, nail lesions are delayed and destructive in nature, despite the clinically resolved cutaneous lesions, and require continual vigilance by pediatricians and dermatologist.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nail lesions
20
incontinentia pigmenti
8
diagnosis management
8
delayed nail
8
nail
7
lesions
7
delayed
4
delayed onychodystrophy
4
onychodystrophy incontinentia
4
pigmenti evidence-based
4

Similar Publications

Lichen planus (LP) is a chronic inflammatory disease that can present with significant morbidity, particularly in children. Erosive lichen planus (ELP), its rare destructive subtype, can be particularly difficult to diagnose and manage. We present a rare pediatric case of ELP with multisite involvement and discuss the differential diagnosis.

View Article and Find Full Text PDF

Precision medicine using molecular-target drugs in psoriatic arthritis.

Ther Adv Musculoskelet Dis

January 2025

The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahata-nishi, Kitakyushu 807-8555, Japan.

Article Synopsis
  • Psoriatic arthritis (PsA) has a range of symptoms like skin lesions, joint pain, and increased risk of cardiovascular issues, highlighting its complexity and impact on lifestyle.
  • Molecular-targeted therapies have been developed that focus on key inflammatory pathways and are now commonly used to manage PsA symptoms, though treatment options can be limited.
  • The shift towards precision medicine, using patient stratification based on blood tests and cytokine levels, aims to enhance treatment efficacy, but more data and new trial designs are essential for its success.
View Article and Find Full Text PDF

: This study is a retrospective analysis of patients with plaque psoriasis treated with biological drugs at a single center in Poland. We sought to evaluate patient demographics, disease characteristics, comorbidity burden, and treatment patterns in this cohort. : Data were collected from the medical records of patients with plaque psoriasis who received biological treatments.

View Article and Find Full Text PDF

This study evaluated the efficacy and safety of Intralesional Acyclovir in the treatment of recalcitrant palmoplantar and ungual warts in 14 patients(7 male and 7 female) of mean age 24.5 +- 8.19 years.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!